Vaccine News and Research

Latest Vaccine News and Research

Researchers detail molecular images of a piece of the spike-shaped protein that the SARS virus uses initiate the first stages of infection

Researchers have determined the first detailed molecular images of a piece of the spike-shaped protein that the SARS virus uses to grab host cells and initiate the first stages of infection.

19 Sep 2005

Making practical markets for vaccines

Two papers published on September 13 in PLoS Medicine raise concerns about whether world leaders are getting good advice on how best to fund the development and delivery of new vaccines.

19 Sep 2005

Less-virulent strain of avian influenza virus can spread from poultry to humans

In findings with implications for pandemic influenza, a new study reports for the first time that a less-virulent strain of avian influenza virus can spread from poultry to humans. The research appears in the October 1 issue of The Journal of Infectious Diseases, now available online.

19 Sep 2005

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

These results show that a natural product of vitamin A can have an important role in regulating immunity and, when administered along with PIC, might be a potentially powerful nutritional-immunological assist in vaccination."

12 Sep 2005

Spread of bird flu to the United States is a "time bomb waiting to go off"

One of the government's top scientists said Monday that the spread of bird flu to the United States is a "time bomb waiting to go off" but that federal and industry efforts to produce a vaccine are progressing.

12 Sep 2005

Vical and NIH to evaluate enhanced-delivery HIV vaccine

Vical Incorporated today announced plans to develop and evaluate electroporation-enhanced delivery of therapeutic and preventive DNA vaccines against HIV

12 Sep 2005

Screening test for cells that activate immune system

UT Southwestern Medical Center researchers are the first to create a large-scale, cell-based screening method that identifies which compounds activate immune-response cells that hold promise for future cancer-fighting vaccines.

12 Sep 2005

Generex Biotechnology granted Canadian patent

Generex Biotechnology Corporation has announced that it has been granted a patent by the Canadian Intellectual Property Office titled "Mixed Micellar Delivery System and Method of Preparation."

12 Sep 2005

Amantadine resistant avian influenza viruses more common in Southeast Asia than North America

Resistance to the antiviral drug amantadine is spreading more rapidly among avian influenza viruses of H5N1 subtype in Southeast Asia than in North America, according to the study done by investigators at St. Jude Children's Research Hospital.

12 Sep 2005

Unexpected link between the viruses that cause feline and human AIDS

A University of Florida researcher has discovered an unexpected link between the viruses that cause feline and human AIDS: Cats vaccinated with an experimental strain of the human AIDS virus appear to be at least as well-protected against the feline version of the disease as those immunized with the vaccine currently used by veterinarians.

10 Sep 2005

Australians consider medical research more important than tax cuts and border protection

Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.

10 Sep 2005

Two die from mosquito-borne disease, experts say public must protect themslves from bites

According to health officials, a rare mosquito-borne disease has killed a young girl and an elderly man who lived in neighboring towns, and they are urging people to protect themselves against the insects.

10 Sep 2005

Two die from mosquito-borne disease, experts say public must protect themslves from bites

According to health officials, a rare mosquito-borne disease has killed a young girl and an elderly man who lived in neighboring towns,and they are urging people to protect themselves against the insects.

7 Sep 2005

Stressgen granted new U.S. patent for treatment of Hepatitis B

Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted Patent Number 6,921,534 covering fusion protein compositions comprised of a hepatitis B virus (HBV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins, and methods of treating an HBV infection using these fusion proteins.

7 Sep 2005

Researchers develop screening test for cells that activate immune system

7 Sep 2005

Collaborators seek parasite invasion blockers

A malaria research team, including WEHI Structural Biologist, Professor Ray Norton, has received a US$1 million grant from the US National Institutes of Health to develop more effective malaria treatments.

7 Sep 2005

Generex Biotechnology awarded Australian patent

Generex Biotechnology Corporation today announced that it has been granted a patent by the Australian Patent Office titled "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation."

6 Sep 2005

Shot in the arm for vaccines

A Flinders University research program to develop new forms of vaccine against infectious diseases has received over $3 million in funding from the United States Government's National Institutes of Health.

6 Sep 2005

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Coronaviruses - the family of viruses that causes the common cold - gained widespread recognition when the deadly severe acute respiratory syndrome, familiarly known as SARS, killed at least 800 people in 2003.

6 Sep 2005

The Measles Initiative partnership a significant reason for success

The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.

6 Sep 2005